Friday’s top analyst upgrades and downgrades included America Movil, Ball, Ciena, Costco Wholesale, Dish Network, Fortinet, Infinera, Levi Strauss, Match, RingCentral, Robinhood Markets and Yum!...
Friday's top analyst upgrades and downgrades included Annaly Capital Management, Carnival, Deere, Freeport-McMoRan, Honest Company, Royal Caribbean Cruises, Shoals Technologies, Take-Two Interactive...
Friday's top analyst upgrades and downgrades included Altice USA, Applied Materials, Block, Coeur Mining, Consolidated Edison, Fastly, Shopify, SM Energy, Tata Motors and Wingstop.
Jefferies is out with its first top growth stock calls for 2021. These four top stock picks could be massive long-term winners, as they have significant catalysts that can drive growth for the rest...
Here are five stocks priced under the $10 level that could provide investors with some solid upside potential. These are not penny stocks with absolutely no track record or liquidity, and major Wall...
After scPhamaceuticals announced that it had received a Complete Response Letter from the FDA, its shares were absolutely crushed on Monday.
DBV Technologies is making a comeback after making headway for its peanut allergy treatment in Europe.
Aquestive Therapeutics said that it had received a negative response from the FDA concerning its treatment for the management of seizure clusters.
These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
Thursday's top analyst upgrades and downgrades included BigCommerce, Exxon, FedEx, Penn National, Rio Tinto, Trillium, Zscaler.
The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.
BioMarin Pharmaceutical stock was crushed on Wednesday after an FDA response regarding its valoctocogene roxaparvovec gene therapy for severe hemophilia A.
Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment of fibrosis due to nonalcoholoic steatohepatitis.
Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Ciena, CommVault Systems, Dollar General, JD.com, Kroger, Nucor, Target and Walmart.
Friday's top analyst upgrades and downgrades included Bill.com, CenterPoint Energy, CommScope, Herbalife, Hyatt Hotels, Motorola Solutions, Murphy Oil, Trade Desk and Vonage.